Business
Nanalysis Scientific Corp. Closes Upsized Public Offering and Non-Brokered Private Placement For Gross Proceeds of $15,224,700
Nanalysis Scientific Corp. Closes Upsized Public Offering and Non-Brokered Private Placem...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n \n \n \n Nanalysis Scientific Corp. Closes Upsized Public Offering and Non-Brokered Private Placement For Gross Proceeds of $15,224,700\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n CALGARY, AB\n \n ,\n \n Feb. 11, 2022\n \n /CNW/ -\n \n \n Nanalysis Scientific Corp.\n \n \n (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (\"Nanalysis\" or the \"Company\") announces that it has closed the previously announced best efforts marketed public offering (the \"Public Offering\") of common shares (the \"Common Shares\") of the Company, including the full exercise of the over-allotment option and the non-brokered private placement of Common Shares (the \"Private Placement\") for combined gross proceeds of\n \n $15,224,700.70\n \n .\n \n \n \n \n \n \n \n \n \n Pursuant to the terms of the Public Offering, the Company issued 11,212,500 Common Shares, including 1,462,500 Common Shares issued pursuant to the exercise of the over-allotment option, at a price per Common Share of\n \n $1.10\n \n for aggregate gross proceeds of\n \n $12,333,750.00\n \n .\n \n \n Echelon Wealth Partners Inc., as lead agent and sole bookrunner, along with Research Capital Corp., acted as the agents for the Public Offering.\n \n \n A total of 2,628,137 Common Shares were issued pursuant to the Private Placement at a price of\n \n $1.10\n \n per Common Shares for gross proceeds to the Company of\n \n $2,890,950.70\n \n .\n \n \n The Company intends to use the net proceeds of the Public Offering for sales, marketing, research and development, acquisitions, general administrative and working capital purposes. The net proceeds from the Private Placement will be used for general corporate and other working capital purposes, as well as additional potential acquisitions.\n \n \n The Common Shares issued pursuant to the Private Placement are subject to a hold period of four months plus one ‎day from the date of closing of the Private Placement. Final acceptance by the TSX Venture Exchange (the \"TSXV\") of the Public Offering and the Private Placement is subject to t...